Authors
Loading...
Systematic review reveals major sample-handling discrepancies across blood-based amyloid-β studies, highlighting the need for standardized pre-analytical protocols in Alzheimer disease screening.
Watt et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: